Table 2 Characteristics of Cancer Survivor Cohort (N=35)
Age at Diagnosis (years; median, range) 7 (0-30)
Time Since Diagnosis (years; median, range) 10 (5-22)
Disease Type Hematologic Malignancy Central Nervous System Tumor Other Solid Tumor BMT for Non-Malignant Condition 18 (51%) 7 (20%) 9 (26%) 1 (3%)
Radiation Central Nervous System Radiation Abdomen/Pelvis Radiation 11 (31%) 9 (26%)
Cyclophosphamide Equivalent Dose (median, range) 2,500 (0-25,200)
Underwent BMT Allogeneic Autologous 5 (14%) 2 (6%)
Received Broad Spectrum Antibiotics During Therapy (%) Yes No Unavailable 23 (66%) 1 (3%) 11 (31%)
Total Days of Broad Spectrum Antibiotics (median, range) Measurement (median, range) Hemoglobin A1c Low-Density Lipoprotein (mg/dL) High-Density Lipoprotein (mg/dL) Adiponectin (ng)- Leptin (pg) Ratio Systolic Blood Pressure (mmHg) Diastolic Blood Pressure (mmHg) Body Mass Index (kg/m2) 44 (0-190) 4.9% (4.2%-5.8%) 81 (26-172) 48 (32-73) 0.61 (0.07-10.56) 118 (101-138) 68 (55-83) 23.7 (14.7-32.6)